Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 3/20 | 0.59 |
| ▸ | CA2 | P00918 | 3/20 | 0.59 |
| ▸ | CA12 | O43570 | 2/20 | 0.59 |
| ▸ | CA7 | P43166 | 2/20 | 0.59 |
| ▸ | CA9 | Q16790 | 2/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.59 |
| ▸ | XDH | P47989 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | CASP1 | P29466 | 1/20 | 0.53 |
| ▸ | CASP7 | P55210 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30029511 | 1.00 | MAPT (0.63) | MAPTGAALMNATDP1CA1 | |
| SCHEMBL16937873 | 0.85 | TDP1 (0.57) | MAPTGAALMNATDP1CA1 | |
| SCHEMBL45823 | 0.85 | KDM4E (0.67) | MAPTGAALMNATDP1CA1 | |
| SCHEMBL6113434 | 0.84 | CES2 (0.53) | MAPTGAALMNATDP1ALDH1A1 | |
| SCHEMBL13830583 | 0.84 | TDP1 (0.57) | MAPTGAALMNATDP1CA1 | |
| 4-Methylbenzoic Acid Methyl Ester SCHEMBL30797091 | 0.84 | TDP1 (0.67) | MAPTGAALMNATDP1CA1 | |
| SCHEMBL30809635 | 0.83 | CA1 (0.71) | MAPTGAALMNATDP1CA1 | |
| SCHEMBL821898 | 0.83 | KDM4E (0.59) | MAPTGAALMNATDP1CA1 | |
| SCHEMBL197972 | 0.83 | CA1 (0.71) | MAPTGAALMNATDP1CA1 | |
| SCHEMBL172476 | 0.83 | CA1 (0.71) | MAPTGAALMNATDP1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4076924-A | CATALYST COMPRISING A TITANIUM COMPONENT AND A GROUP I TO III ORGANO-METAL COMPOUND | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JA) | 1978-02-28 | — | — | US | claimed |
| EP-4536363-A1 | SULFAMIDE DERIVATIVES AS CYCLIN-DEPENDENT KINASE 2 INHIBITORS | Nikang Therapeutics, Inc. (US) | 2025-04-16 | — | — | EP | disclosed |
| US-20240408216-A1 | PROTEIN INHIBITOR OR DEGRADING AGENT, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PHARMACEUTICAL USE | JING MEDICINE TECHNOLOGY (SHANGHAI) LTD. (CN) | 2024-12-12 | — | — | US | disclosed |
| US-12097629-B2 | Razor cartridge | BIC Violex Single Member S.A. (GR) | 2024-09-24 | — | — | US | disclosed |
| EP-4361163-A1 | PROTEIN INHIBITOR OR DEGRADING AGENT, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PHARMACEUTICAL USE | JING MEDICINE TECHNOLOGY (SHANGHAI) LTD. (CN) | 2024-05-01 | — | — | EP | disclosed |
| US-11919183-B2 | Razor cartridge | BIC Violex Single Member S.A. (GR) | 2024-03-05 | — | — | US | disclosed |
| EP-3869268-B1 | MATERIAL FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND POLYMER | SHINETSU CHEMICAL CO (JP) | 2024-01-17 | — | — | EP | disclosed |
| US-20240009874-A1 | RAZOR CARTRIDGE | BIC Violex Single Member S.A. (GR) | 2024-01-11 | — | — | US | disclosed |
| WO-2023240024-A1 | SULFAMIDE DERIVATIVES AS CYCLIN-DEPENDENT KINASE 2 INHIBITORS | NIKANG THERAPEUTICS, INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| CN-117203216-A | Protein inhibitor or degradation agent, pharmaceutical composition containing same and medical application | 和径医药科技（上海）有限公司 | 2023-12-08 | — | — | CN | disclosed |
| EP-0464959-A2 | Naphthalocyanine derivatives and production processes thereof, as well as optical information recording media using the derivatives and production processes thereof | Hitachi Chemical Co., Ltd. (JP) | 1992-01-08 | — | — | EP | disclosed |
| US-5026856-A | Bactericides | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1991-06-25 | — | — | US | disclosed |
| US-5015777-A | Reaction of an acetophenone and an aliphatic ester or an ester of benzoic acid in the presence of sodium alkoxide condensation agent in an aromatic solvent | WITCO CORPORATION (US) | 1991-05-14 | — | — | US | disclosed |
| EP-0343560-A2 | Isoindoline derivative | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1989-11-29 | — | — | EP | disclosed |
| CN-1037163-A | Carbon black filled foams | CELOTEX CORP (US) | 1989-11-15 | — | — | CN | disclosed |
| EP-0182872-B1 | A PROCESS FOR THE PREPARATION OF CYCLOBUTENE-SUBSTITUTED AROMATIC HYDROCARBONS | THE DOW CHEMICAL COMPANY (US) | 1989-11-08 | — | — | EP | disclosed |
| US-4833264-A | INTERMEDIATES FOR NAPHTHALOCYANINE DYES | HITACHI CHEMICAL CO., LTD. (JP) | 1989-05-23 | — | — | US | disclosed |
| EP-0284369-A2 | 5- or 6-alkoxycarbonyl-2,3-dicyanonaphthalenes and process for production thereof | Hitachi Chemical Co., Ltd. (JP) | 1988-09-28 | — | — | EP | disclosed |
| EP-0284370-A2 | Naphthalocyanine derivatives and production processes thereof, as well as optical information recording media using the derivatives and production processes thereof | Hitachi Chemical Co., Ltd. (JP) | 1988-09-28 | — | — | EP | disclosed |
| US-4076924-A | CATALYST COMPRISING A TITANIUM COMPONENT AND A GROUP I TO III ORGANO-METAL COMPOUND | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JA) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240408216-A1 | PROTEIN INHIBITOR OR DEGRADING AGENT, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PHARMACEUTICAL USE | PSME1, IDE, PRUNE1 | MAPT 388/4885GAA 250/4885LMNA 1363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.